People
John Davis
John Davis is listed by EndLyz Therapeutics as Scientific Co-Founder. Published current affiliation reviewed October8,2026; exact appointment day is not established. John Davis is a published External Drug Discovery Adviser with the Parkinson’s Research Ventures programme. Own biography: John Davis is Professor of Pharmaceutical Discovery in the Nuffield Department of Medicine, University of Oxford, and a principal investigator within the Centre for Medicines Discovery. As director of business development for the Alzheimer’s Research UK Drug Discovery Alliance (ARUK DDA), John is focused on building partnerships that capitalise on the strengths of the 3 drug discovery institutes within the ARUK DDA. In 2015, John joined the University of Oxford to establish the ARUK Oxford Drug Discovery Institute. The institute has developed a portfolio of early drug discovery programmes for Alzheimer’s and Parkinson’s, with an emphasis on genetically validated targets, and has forged multiple industrial alliances to accelerate project progression. John has 30 years of drug discovery expertise and has helped steer a number of drug candidates into development. The adviser/operating affiliation is distinct from a statutory directorship or personal cash check.
Roles
Scientific Co-Founder
External Drug Discovery Adviser